Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15703816rdf:typepubmed:Citationlld:pubmed
pubmed-article:15703816lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0009429lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0598934lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C2677316lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15703816lifeskim:mentionsumls-concept:C0950779lld:lifeskim
pubmed-article:15703816pubmed:issue3lld:pubmed
pubmed-article:15703816pubmed:dateCreated2005-2-10lld:pubmed
pubmed-article:15703816pubmed:abstractTextTNP-470, a potent inhibitor of angiogenesis, was reported to synergistically enhance the antitumor effects of cytotoxic agents. The objective of this study was to evaluate the effectiveness of combined treatment with TNP-470 and docetaxel both in vitro and in vivo using androgen-independent human prostate cancer PC-3 cells. The in vitro growth-inhibitory and apoptotic effects of docetaxel and/or TNP-470 on PC-3 cells were assessed using MTT and TUNEL assays. The combined effect of docetaxel and TNP-470 therapy after subcutaneous and orthotopic injection of PC-3 cells into athymic nude mice was evaluated. In vivo effects of this combined regimen on PC-3 tumors were analyzed by the TUNEL assay and immunohistochemical staining of CD31 to quantify microvessel density (MVD). Combined treatment with TNP-470 and docetaxel synergistically inhibited PC-3 cell growth in vitro through the enhanced induction of apoptotic cell death compared with treatment with either agent alone, a result explained, at least in part, by the down-regulation as well as phosphorylation of potential anti-apoptotic genes, Bcl-2 and Bcl-XL. Combined treatment with TNP-470 and docetaxel synergistically suppressed subcutaneous PC-3 tumor growth compared with treatment with either agent alone. Furthermore, this combined regimen significantly inhibited orthotopic PC-3 tumor growth and reduced the incidence of lymph node metastasis. Immunohistochemical analysis of the subcutaneous tumor after each treatment demonstrated that administration of docetaxel as well as TNP-470 significantly induced apoptotic cell death; in contrast, a significant reduction in MVD was observed only after TNP-470. These findings suggest that docetaxel and TNP-470 act synergistically to inhibit PC-3 tumor growth and metastasis, by enhancing apoptosis and suppressing angiogenesis.lld:pubmed
pubmed-article:15703816pubmed:languageenglld:pubmed
pubmed-article:15703816pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:citationSubsetIMlld:pubmed
pubmed-article:15703816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15703816pubmed:statusMEDLINElld:pubmed
pubmed-article:15703816pubmed:monthMarlld:pubmed
pubmed-article:15703816pubmed:issn1019-6439lld:pubmed
pubmed-article:15703816pubmed:authorpubmed-author:KamidonoSadao...lld:pubmed
pubmed-article:15703816pubmed:authorpubmed-author:MiyakeHideaki...lld:pubmed
pubmed-article:15703816pubmed:authorpubmed-author:HaraIsaoIlld:pubmed
pubmed-article:15703816pubmed:authorpubmed-author:MuramakiMotot...lld:pubmed
pubmed-article:15703816pubmed:issnTypePrintlld:pubmed
pubmed-article:15703816pubmed:volume26lld:pubmed
pubmed-article:15703816pubmed:ownerNLMlld:pubmed
pubmed-article:15703816pubmed:authorsCompleteYlld:pubmed
pubmed-article:15703816pubmed:pagination623-8lld:pubmed
pubmed-article:15703816pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:meshHeadingpubmed-meshheading:15703816...lld:pubmed
pubmed-article:15703816pubmed:year2005lld:pubmed
pubmed-article:15703816pubmed:articleTitleSynergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model.lld:pubmed
pubmed-article:15703816pubmed:affiliationThe Prostate Centre, Jack Bell Research Centre, Vancouver, British Columbia V6H 3Z6, Canada. mmuramak@vanhosp.bc.calld:pubmed
pubmed-article:15703816pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15703816lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15703816lld:pubmed